Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$19,084,627
+$2,921,424 QoQ
Shares Held
75,841
+2.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#629
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BTC Capital Management, Inc. holds $72,536,732 across 7 Drug Manufacturers - General names. ABBV ranks #1 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
75,841 | $19,084,627 | |
| 2 | JNJ |
Johnson & Johnson
|
71,998 | $18,285,330 | |
| 3 | LLY |
ELI LILLY & Co
|
13,431 | $16,109,544 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
113,516 | $14,341,610 | |
| 5 | NVS |
Novartis AG
|
16,933 | $2,653,739 | |
| 6 | SNY |
Sanofi
|
43,138 | $1,840,266 | |
| 7 | AMGN |
Amgen Inc
|
612 | $221,616 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,084,627 | 75,841 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $16,163,203 | 74,317 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $16,432,084 | 71,916 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $16,834,347 | 72,706 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,807,778 | 69,000 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $13,007,419 | 62,082 | Shares | Defined | 2025-04-08 | |
| 2024-12-31 | $11,507,495 | 64,758 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $13,271,444 | 67,204 | Shares | Defined | 2024-10-21 | |
| 2024-06-30 | $12,189,582 | 71,068 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $12,946,034 | 71,093 | Shares | Sole | 2024-04-11 | |
| 2023-09-30 | $11,182,927 | 75,023 | Shares | Defined | 2023-10-17 | |
| 2023-06-30 | $9,961,665 | 73,938 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $11,912,427 | 74,747 | Shares | Defined | 2023-04-07 | |
| 2022-12-31 | $12,034,772 | 74,468 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,723,115 | 42,643 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $5,564,148 | 36,329 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,184,496 | 38,150 | Shares | Defined | 2022-05-06 | |
| 2021-12-31 | $6,712,589 | 49,576 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $5,088,443 | 47,172 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,608,682 | 49,793 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $5,409,809 | 49,989 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $4,914,220 | 45,863 | Shares | Defined | 2021-01-28 | |
| 2020-09-30 | $2,938,118 | 33,544 | Shares | Defined | 2020-10-14 | |
| 2020-06-30 | $3,378,569 | 34,412 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $2,777,428 | 36,454 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||